Real-world treatment patterns and outcomes among patients with HER2-positive unresectable or metastatic breast cancer in China
The results of this study provide valuable real-world insight into HER2 positive mBC treatment trends and clinical outcomes, informing subsequent patient management.
Authors
- Zhongsheng Tong (ORCID: https://orcid.org/0000-0003-4569-1311)
- Tao Sun (ORCID: https://orcid.org/0000-0001-7255-9039)
- Xiaojia Wang (ORCID: https://orcid.org/0000-0002-7005-0842)
- Lihua Song
- Limin Chen (ORCID: https://orcid.org/0000-0002-2107-0441)
- Shusen Wang
- Jiajia Huang
- Yi Liu (ORCID: https://orcid.org/0009-0007-8292-3296)
Institutions
- Sun Yat-sen University (CN)
- Daiichi Sankyo (Germany) (DE)
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Zhejiang Cancer Hospital (CN)
- Shandong Tumor Hospital (CN)
- Sun Yat-sen University Cancer Center (CN)
- Liaoning Cancer Hospital & Institute (CN)
- Shandong First Medical University (CN)
- Hangzhou Cancer Hospital (CN)
- China Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-05-14
- DOI
- https://doi.org/10.3389/fonc.2025.1527990
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00